XML 17 R6.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Unaudited Condensed Consolidated Statements of Changes in Stockholders' Equity (Deficit) - USD ($)
$ in Thousands
Total
Revision of Prior Period, Adjustment
Impact of ASC 326 adoption
Revision of Prior Period, Adjustment
Common Stock
Additional Paid-In Capital
Non controlling Interests
Accumulated Deficit
Accumulated Deficit
Impact of ASC 326 adoption
Treasury Stock
Beginning balance at Dec. 31, 2022 $ 85                
Redeemable Noncontrolling Interests                  
Purchase accounting measurement period adjustments 240                
Capital distributions to noncontrolling interests (108)                
Net income (loss) (39)                
Ending balance at Mar. 31, 2023 178                
Balance (in shares) at Dec. 31, 2022       18,046,903          
Balance at Dec. 31, 2022 288,891   $ 1,285 $ 2 $ 473,289 $ 8,942 $ (193,342) $ 1,285 $ 0
Treasury stock, beginning balance (in shares) at Dec. 31, 2022                 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Purchase accounting measurement period adjustments   $ (7,303)     (1,813) (5,490)      
Exercise of stock options (in shares)       135,210          
Exercise of stock options 283       283        
Issuance of restricted stock (in shares)       341,490          
Issuance of common stock (in shares)       25,818          
Issuance of common stock 150       150        
Capital distributions to noncontrolling interests (88)         (88)      
Stock-based compensation expense 796       796        
Net income (loss) (18,805)         590 (19,395)    
Balance (in shares) at Mar. 31, 2023       18,549,421          
Balance at Mar. 31, 2023 265,209     $ 2 472,705 3,954 (211,452)   $ 0
Treasury stock, ending balance (in shares) at Mar. 31, 2023                 0
Balance (in shares) at Dec. 31, 2023       19,093,186          
Balance at Dec. 31, 2023 $ 214,669     $ 2 475,654 2,325 (257,888)   $ (5,424)
Treasury stock, beginning balance (in shares) at Dec. 31, 2023 800,650               800,650
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Issuance of restricted stock (in shares)       5,060          
Capital distributions to noncontrolling interests $ (76)         (76)      
Stock-based compensation expense 821       821        
Net income (loss) (2,450)         4 (2,454)    
Balance (in shares) at Mar. 31, 2024       19,098,246          
Balance at Mar. 31, 2024 $ 212,964     $ 2 $ 476,475 $ 2,253 $ (260,342)   $ (5,424)
Treasury stock, ending balance (in shares) at Mar. 31, 2024 800,650               800,650